The 1st hour … which RegMed companies are making moves
Signs of life …
Pluristem (PSTI +$0.10), Opexa (OPXA +$0.12), Harvard Bio (HBIO +$0.09) are the early leaders
followed by the pack of BioTime (NYSE MKT: BTX +$0.03), ThermoGenesis (KOOL +$0.02), Cytomedix (OTC: QX: CMXI +$0.018 – post financing – a Ho-Ra for them), International Stem Cell (OTC: ISCO +$0.017), NeoStem (NYSE MKT: NBS +$0.008), Fibrocell (OTC: FCSC +$0.003).
A view of the downside at the open …
Shire (SHPG -$0.32), Osiris (OSIR -$0.25), Stemline (STML -$0.19 was -$0.88 – beginning to have doubts about meteoric rise), Dendreon (DNDN -$0.19) are the loss leaders for the open
followed by Athersys (ATHX -$0.08), Wright-Medical (WMGI -$0.08), Cytori (CYTX -$0.07), Proteonomix (PINK: PROT +$0.05), BioMimetic (BMTI -$0.04 was $0.05), Geron (GERN -$0.02), Neuralstem (NYSE MKT: CUR -$0.01, Verastem (VSTM -$0.01), MiMedx (PINK: MDXG -$0.02), StemCells (STEM -$0.05), ImmunoCellular (NYSE MKT: IMUC -$0.07), Aastrom (ASTM -$0.03) and Advanced Cell Technology (OTC: ACTC -$0.0006)
12 flats